CHTH — CNL Healthcare Properties Income Statement
0.000.00%
Last trade - 00:00
- $446.95m
- $967.68m
- $341.48m
- 61
- 77
- 24
- 53
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 326 | 307 | 295 | 323 | 341 |
Cost of Revenue | |||||
Gross Profit | 123 | 99.9 | 84.9 | 81.1 | 87.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 284 | 285 | 296 | 305 | 327 |
Operating Profit | 41.6 | 21.7 | -0.177 | 17.2 | 14.7 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 4.28 | 4.16 | -18.7 | 0.128 | -25.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.07 | 3.06 | -22.9 | -0.412 | -25.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 351 | 3.91 | -22.9 | -1.45 | -25.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 351 | 3.91 | -22.9 | -1.45 | -25.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.014 | 0.012 | -0.095 | -0.063 | -0.151 |
Dividends per Share | |||||
Special Dividends per Share |